Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 25 2018

Full Issue

Massive Sepsis Trial Resembles 'An Experiment That Would Be Conducted On Laboratory Animals,' Advocates Say

Sepsis can be a catastrophic, life-threatening condition, and patients in the study require critical care. But, in an effort to determine which method works best against sepsis, the patients are limited to one type of treatment. In other public health news, malaria, birth centers, Ebola, and recovery from paralysis.

The New York Times: Trial By Fire: Critics Demand That A Huge Sepsis Study Be Stopped

A large government trial comparing treatments for a life-threatening condition called sepsis is putting participants at risk of organ failure and even death, critics charge, and should be immediately shut down. A detailed analysis of the trial design prepared by senior investigators at the National Institutes of Health Clinical Center in Bethesda, Md., concluded that the study “places seriously ill patients at risk without the possibility of gaining information that can provide benefits either to the subjects or to future patients.” (Rabin, 9/24)

The New York Times: Giving Malaria A Deadline

Malaria is among the world’s worst scourges. In 2016 the disease, which is caused by a parasite and transmitted by mosquitoes, infected 194 million people in Africa and caused 445,000 deaths. But biologists now have developed a way of manipulating mosquito genetics that forces whole populations of the insect to self-destruct. The technique has proved so successful in laboratory tests that its authors envisage malaria could be eliminated from large regions of Africa within two decades. (Wade, 9/24)

The New York Times: Should You Give Birth At A Birth Center?

When Gillian Tarr became pregnant with her second child, she chose a free-standing birth center in Seattle for her prenatal care and delivery. Her first baby had been born in a hospital, and while it was a relatively uncomplicated birth, she felt dissatisfied with the care she received. “It was impersonal and lacked any real support,” said Dr. Tarr, an epidemiologist now living in Calgary, Alberta. (Callahan, 9/25)

The Associated Press: WHO Warns Of ‘Perfect Storm’ For Ebola In Eastern Congo

The emergencies chief for the World Health Organization says insecurity, public defiance about vaccinations and political jockeying could create a “perfect storm” leading Congo’s latest Ebola outbreak to spread. Dr. Peter Salama says the response is at a “critical juncture” in eastern North Kivu province, where the outbreak was declared nearly two months ago. Health officials have counted 150 confirmed and probable cases, including over 100 deaths. (9/25)

The Associated Press: Implant, Intense Rehab Help 3 Paralyzed For Years Take Steps

Three people whose legs were paralyzed for years can stand and take steps again thanks to an electrical implant that zaps the injured spinal cord — along with months of intense rehab, researchers reported Monday. The milestone, reported by two teams of scientists working separately, isn't a cure. The patients walk only with assistance — holding onto a rolling walker or with other help to keep their balance. Switch off the spinal stimulator and they no longer can voluntarily move their legs. (Neergaard, 9/24)

The Washington Post: Paralyzed People Are Beginning To Walk With A New Kind Of Therapy

Kelly Thomas woke up in a Florida hospital four years ago with no recollection of the car accident that had robbed her of the ability to walk. Thomas, an active college student who had barrel raced in rodeos, moved to Kentucky for a year to try out a research study that she hoped would retrain her spinal cord on how to walk. In February, a trainer who had been scooting along the floor at Thomas’s feet, helping her move her legs and place her feet as she used a walker, stopped and stood up. (Johnson, 9/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF